Atlas Trials

Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary

Clinical trial NCT04325425 · RECRUITING

Trial details

NCT number
NCT04325425
Sponsor
Centre Hospitalier Universitaire Dijon
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Carcinoma
Start date
2020-09-01
Primary completion
2029-09-01
Enrollment
218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.